Hepatocyte growth factor and C-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma

Hepatology

Volumn 24, Issue 3, 1996, Pages 596-602

  Nakayama, Nobuaki ^a,c   Kashiwazaki, Haruhiko ^a   Kobayashi, Narumi ^a   Hamada, Jun Ichi ^a   Ogiso, Yoshifumi ^b   Itakura, Yasushi ^d   Matsumoto, Kunio ^d   Nakamura, Toshikazu ^d   Koike, Takao ^c   Kuzumaki, Noboru ^b   Takeichi, Noritoshi ^a  

^a Laboratory of Molecular Genetics   (Japan)

^b CANCER INSTITUTE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ACUTE HEPATITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WILSON DISEASE;

EID: 16044364386     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781331     Document Type: Article

References (54)

1. Yoshida MC, Masuda R, Sasaki M, Takeichi N, Kobayashi H, Dempo K, Mori M. New mutation causing hereditary hepatitis in the laboratory rat. J Hered 1987;78:361-365.
2. Takeichi N, Kobayashi H, Yoshida MC, Sasaki M, Dempo K, Mori M. Spontaneous hepatitis in Long-Evans rats: a potential animal model for fulminant hepatitis in man. Acta Pathol Jpn 1988;38:1369-1375.
3. Masuda R, Yoshida MC, Sasaki M, Dempo K, Mori M. High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res 1988;79:828-835.
4. Li Y, Togashi Y, Sato S, Emoto T, Kang J, Takeichi N, Kobayashi H, et al. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis: a model of Wilson's disease. J Clin Invest 1991;87:1858-1861.
5. Li Y, Togashi Y, Sato S, Emoto T, Kang J, Takeichi N, Kobayashi H, et al. Abnormal copper accumulation in non-cancerous and cancerous liver tissues of LEC rats developing hereditary hepatitis and spontaneous hepatoma. Jpn J Cancer Res 1991;82:490-492.
6. Togashi Y, Li Y, Kang J, Takeichi N, Fujioka Y, Nagashima K, Kobayashi H. D-Penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism. HEPATOLOGY 1992;15: 82-88.
7. Kang J, Togashi Y, Kasai H, Hosokawa M, Takeichi N. Prevention of spontaneous hepatocellular carcinoma in Long-Evans Cinnamon rats with hereditary hepatitis by the administration of D-Penicillamine. HEPATOLOGY 1993;18:614-620.
8. Wu J, Forbes JR, Chen HS, Cox DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 1994;7:541-545.
9. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocytes growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
10. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987;224:311-318.
11. Gohda E, Tsubouchi H, Nakayama H, Hirano S, Sakiyama O, Takahashi K, Miyazaki H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of patient with hepatic failure. J Clin Invest 1988;81:414-419.
12. Zarnegar R, Michalopoulos GK. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989;49:3314-3320.
13. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude GF. Sequence of met protooncogene cDNA has features characteristic of the tyrosine kinase receptors. Proc Natl Acad Sci U S A 1987;84:6379-6383.
14. Giord S, Ponzetto C, Di Renzo MF, Copper CS, Comoglio PM. Tyrosin kinase receptor distinguishable from the c-met protein. Nature 1989;399: 155-156.
15. Higuchi O, Nakamura T. Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. Biochem Biophys Res Commun 1991;176:599-607.
16. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Wounde GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-804.
17. Naldini L, Vigna E, Narsimham RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991;6:501-504.
18. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
19. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 1992;3:27-54.
20. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has potent antihepatitis action in vivo. HEPATOLOGY 1992;16: 1227-1235.
21. Weidner KM, Behrens J, Vanderkerckhove J, Birckmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990;111:2097-2108.
22. Gherardi E, Stoker M. Hepatocytes and scatter factor. Nature 1990;346: 228.
23. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67:901-908.
24. Johnson M, Koukoulis G, Matsumoto K, Nakamura T, Iyer A. Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. HEPATOLOGY 1993;17:1052-1061.
25. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Wounde GF. The met protooncogene receptor and lumen formation. Science 1992;257: 1258-1261.
26. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, et al. Levels of the human hepatocyte growth factor in serum of patient with various liver diseases determined by an enzyme-linked immunosorbent assay. HEPATOLOGY 1991;13:1-5.
27. Tashiro K, Hagiya M, Nishizawa T, Seki T, Shimonishi M, Shimizu S, Nakamura T. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci USA 1990;87:3200-3204.
28. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 1989;165:1229-1234.
29. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990;173:42-47.
30. Kinoshita T, Hirao S, Matsumoto K, Nakamura T. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem Biophys Res Commun 1991;177:330-335.
31. Zarnegar R, DeFrance MC, Kost DP, Michalopoulos GK. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991;177:559-565.
32. Ramadori G, Neubauer K, Odenthal T, Nakamura T, Knittel T, Schwogler S, Meyer zum Buschenfelde KH. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-β. Biochem Biophys Res Commun 1992;183:739-742.
33. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992;182:802-809.
34. Higgins GM, Anderson RM. Experimental pathalogy of the liver. 1. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol Lab Med 1931;12:186-202.
35. Arber N, Zajicek G, Shamir R, Kenet G, Raanani P, Nordenberg J, Sidi Y. Bromobenzene accelerates hepatocyte streaming in rats. Gastroenterology 1992;103:1273-1276.
36. Matsumoto K, Okazaki H, Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 1992;188:235-243.
37. Matsumoto K, Tajima H, Hamanoue M, Kohno S, Kinoshita T, Nakamura T. Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA 1992; 89:3800-3804.
38. Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, et al. Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 1994;127:225-234.
39. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeisson SS. Cellular distribution of transforming growth factor-β1 and procollagen types 1, 3 and 4 transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990;85:1833-1843.
40. Czaja MJ, Weiner F/R, Flanders KC, Giambrone MA, Wind R, Biempica L, Zern M. In vitro and in vivo association of transforming growth factor-b1 with hepatic fibrosis. J Cell Biol 1989;108:2477-2482.
41. Nakamura T, Tomita Y, Hiarai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985;133: 1042-1050.
42. Russell WE, Coffey RJ Jr., Ouellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988;85:5126-5130.
43. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
44. Matsumoto K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β1 and glucocorticoids. J Biol Chem 1992;267:24917-24920.
45. Joplin R, Hishida T, Tsubouchi H, Daikuhara Y, Ayres R, Neuberger JM, Strain AJ. Human intrahepatic biliary epitherial cells proliferate in vitro in response to human hepatocyte growth factor. Clin Invest Med 1992;90: 1284-1289.
46. Yoshinaga Y, Matsuno Y, Fijita S, Nakamura T, Kikuchi M, Shimosato Y, Hirohashi S. Immunohistochemical detection of hepatocyte growth factor/ scatter factor in human cancerous and inflammatory lesion of various organs. Jpn J Cancer Res 1993;84:1150-1158.
47. Tsao MS, Zhu H, Giaid A, Viallet J, Nakamura T, Morag P. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epitherial and lung carcinoma cells. Cell Growth Differ 1993;4:571-579.
48. Kanda H, Tajima H, Lee GH, Nomura K, Ohtake K, Matsumoto K, Nakamura T, et al. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. Oncogene 1993;8:3047-3053.
49. Ebert M, Yokoyama M, Freiss H, Buchler MW, Korc M. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994;54:5775-5778.
50. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A 1992;89:373-377.
51. Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994;9:2045-2052.
52. Liu Y, Lin L, Zarnegar R. Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary. Mol Cell Endocrinol 1994;104:173-181.
53. Hughes RD, Yamada H, Gove CD, Williams R. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure. Dig Dis Sci 1991;36:816-819.
54. Yamada H, Toda G, Yoshiba M, Hashimoto N, Ikeda Y, Mitsui H, Kurokawa K, et al. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure. HEPATOLOGY 1994;19:1133-1140.